# Q5A(R2) Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/q5ar2-viral-safety-evaluation-of-biotechnology-products-derived-from-cell-lines-of-human-or-animal-origin/5176fb4c-a3d2-4aaf-85d0-dd246f7a9db1

> FDA guidance document: Q5A(R2) Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin. Issue date: January 10, 2024. Get complete insights and analysis.

---

## Details

- Title: Q5A(R2) Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2024-01-10
- Last Changed: 2024-01-12
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2022-D-2512">FDA-2022-D-2512</a>

## Related Documents

- [Providing Regulatory Submissions in Electronic Format: IND Safety Reports Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/providing-regulatory-submissions-in-electronic-format-ind-safety-reports-guidance-for-industry/d8a7e884-2739-4461-b12b-7feef9321c17)
- [Risk Evaluation and Mitigation Strategies: Modifications and Revisions Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/risk-evaluation-and-mitigation-strategies-modifications-and-revisions-guidance-for-industry/97c2bcd1-cfbd-4928-92c1-d3ac287909b5)
- [Q2(R2) Validation of Analytical Procedures](https://www.globalkeysolutions.net/guidances/guidance-document/q2r2-validation-of-analytical-procedures/2fb8b117-5251-4360-87db-a581ceb120a0)